Showing results (831-840 of 4,212) with videos related to
Sort By:
Pageof 422
Discover Oncology|June 2, 2023
Tetrandrine citrate suppresses lung adenocarcinoma growth via SLC7A11/GPX4-mediated ferroptosisXiaocong Mo, Di Hu, Kaisheng Yuan, et al.Discover Oncology|June 5, 2023
ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancerWeihao Zhang, Yongjie Xie, Xin Yu, et al.Discover Oncology|May 26, 2023
Hyperthermia promotes M1 polarization of macrophages via exosome-mediated HSPB8 transfer in triple negative breast cancerDi Xu, Zhen Liu, Ming-Xing Liang, et al.Discover Oncology|May 27, 2023
Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinomaHewen Shi, Ying Zou, Xiaoxue Wang, et al.Discover Oncology|June 5, 2023
SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patientsRan Zeng, Xiaoyun Fan, Jin Yang, et al.Discover Oncology|June 6, 2023
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)Wan-Soo Yoon, Jong Hee Chang, Jeong Hoon Kim, et al.Discover Oncology|June 3, 2023
CircHIPK3 negatively regulates autophagy by blocking VCP binding to the Beclin 1 complex in bladder cancerChong Wang, Tiantian Liu, Jiawei Wang, et al.Discover Oncology|May 27, 2023
Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxelHuming Wang, Xiangyu Teng, Yuan Lin, et al.Discover Oncology|February 23, 2026
Multi-dimensional analysis reveals the potential of PDK4 as a tumor biomarker and target for immunotherapyYaxing Deng, Xin Wang, Mei Zeng, et al.Discover Oncology|March 9, 2026
Emerging role of lncRNA TP53TG1 as a tumor regulator and biomarker in human malignanciesBing Wang, Tingting Yu, Lei Luo, et al.Pageof 422